Physician profile
Lori Joy
NPI 1285748368
$1,400.35
in general payments reported to CMS, 2019-2025
19 companies · $64.50 in 2025
The $64.50 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.06 · 2020: $45.22 · 2021: $170 · 2022: $411 · 2023: $321 · 2024: $290 · 2025: $64.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.01 | 2019-2024 | |
| Astellas Pharma US INC | $208.08 | 2022-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $153.64 | 2019-2024 | |
| Hologic Sales and Service, LLC | $118.30 | 2020-2024 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Coopersurgical, INC. | $67.15 | 2019-2024 | Paragard T 380a |
| Exeltis, USA INC. | $51.55 | 2022-2023 | Slynd |
| Therapeuticsmd, INC. | $50.30 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $47.11 | 2025 | Myfembree |
| Allergan, INC. | $46.40 | 2019-2021 | |
| Sage Therapeutics, LLC | $42.14 | 2024-2025 | Zurzuvae |
| Organon LLC | $40.14 | 2022-2024 | |
| Myovant Sciences INC. | $38.98 | 2022 | |
| Smith+Nephew, INC. | $25.47 | 2021 | |
| Ethicon US, LLC | $21.92 | 2023 | Monocryl, Dermabond Prineo, Stratafix |
| Pacira Pharmaceuticals Incorporated | $18.84 | 2023 | Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.95 | 2024 | Injectafer |
| Olympus America INC. | $17.57 | 2022 | |
| Agile Therapeutics, INC. | $13.52 | 2024 | Twirla |
| Pfizer INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.